Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody

Intramuscular administration of mesenchymal stromal cells (MSCs) represents a therapeutic option for diabetic critical limb ischemia. Autologous or allogeneic approaches may be used but disease-induced cell dysfunction may limit therapeutic efficacy in the former. Our aim was to compare the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, A., Baustian, C., Thomas, D., Vaughan, E., Sanz-Nogués, C., Creane, M., Chen, X., Alagesan, S., Owens, P., Horan, J., Dockery, P., Griffin, M. D., Duffy, A., O’Brien, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434464/
https://www.ncbi.nlm.nih.gov/pubmed/30016879
http://dx.doi.org/10.1177/0963689718784862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434464/
https://www.ncbi.nlm.nih.gov/pubmed/30016879
http://dx.doi.org/10.1177/0963689718784862

Ejemplares similares